Search filters

List of works by Miles C Andrews

A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme

scientific article published on 01 April 2014

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

scientific article published on 15 June 2022

Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

scientific article published on 01 December 2018

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

scientific article published on 2 March 2018

BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.

scientific article published on 4 November 2013

Cancer Evolution during Immunotherapy.

scientific article published in November 2017

Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma

scientific article published on 22 July 2015

Characterization of the treatment-naive immune microenvironment in melanoma with <i>BRAF</i> mutation

scientific article published on 01 April 2022

Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

scientific article published on 21 October 2019

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.

scientific article published on 4 May 2018

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

scientific article published on 9 August 2017

Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells

scientific article

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

scientific article published on 28 April 2016

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.

scientific article published on 18 May 2017

Evolving role of tumor antigens for future melanoma therapies.

scientific article

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

scientific article published on 2 November 2017

Hallmarks of response to immune checkpoint blockade

scientific article

Human perforin mutations and susceptibility to multiple primary cancers

scientific article

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

scientific article

Immunotherapy resistance: the answers lie ahead - not in front - of us.

scientific article published on 21 February 2017

Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma

scientific article published on 11 May 2016

MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.

scientific article

MEK inhibition, alone or in combination with BRAF inhibition, impairs multiple functions of isolated normal human lymphocytes and dendritic cells.

scientific article published on 7 November 2013

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

scientific article published on 8 October 2018

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

scientific article

Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats.

scientific article published in August 2004

Non-HIV-associated Kaposi sarcoma in an immunosuppressed melanoma patient treated with dabrafenib

scientific article published on 28 February 2016

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

scientific article published on 28 June 2017

Patterns of care for metastatic renal cell carcinoma in Australia.

scientific article published on 21 July 2015

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

scientific article published on 01 December 2018

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

scientific article published on 21 March 2017

Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma.

scientific article published on 10 November 2014

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma

scientific article published on 15 April 2020

Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma

scientific article published on 12 February 2020

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

scientific article published on 03 September 2019

Systems analysis identifies miR-29b regulation of invasiveness in melanoma.

scientific article

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure

scientific article published on 12 June 2017

The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression

scientific article published in March 2018

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

scientific article

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

scientific article published on 3 July 2014

The nitric oxide system in glucocorticoid-induced hypertension

scientific article

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

scientific article published on 4 November 2015

Paulina is supported by:

About Paulina

Help